Interim Data From Two Ongoing Investigator-initiated Trials Highlight the Role of Sculptra and Resty
New interim results from a six-month investigator-initiated trial (IIT) supported by Galderma, regarding the clinical sequencing of women in menopause, show the combination of Restylane Skinboosters and Sculptra drove meaningful improvements in skin barrier function, hydration and patient satisfaction, with the most pronounced gains in hydration
来源：
作者：
